QUALITY CONTROL MEASUREMENT AND IN VITRO BIOEQUIVALENCE OF VALSARTAN AND ATENOLOL TABLETS MARKETED IN UKRAINE
Background. The urgent issue of hypertension is determined by its high population incidence, significant burden of the disease, risk of disability and impact on life expectancy. Rational combinations of drugs of different pharmacological groups in case of ineffectiveness of monotherapy to achieve th...
Main Author: | K. Y. Peleshok |
---|---|
Format: | Article |
Language: | English |
Published: |
Ukrmedknyha
2021-05-01
|
Series: | International Journal of Medicine and Medical Research |
Subjects: | |
Online Access: | https://ojs.tdmu.edu.ua/index.php/ijmr/article/view/12013 |
Similar Items
-
Quantifying pharmacodynamic interaction between atenolol and valsartan
by: Rausova Zuzana, et al.
Published: (2014-02-01) -
In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria
by: C.O. Esimone, et al.
Published: (2008-02-01) -
Pharmacokinetics and safety of highly variable valsartan in single-pill combination with amlodipine versus its generic formulation: a randomized, three-cycle, three-sequence, partially replicated crossover phase I bioequivalence clinical trial
by: Bo Qiu, et al.
Published: (2023-09-01) -
An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence
by: Marilena Vlachou, et al.
Published: (2021-01-01) -
Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions
by: Wu Q, et al.
Published: (2020-10-01)